Understanding the Genetic Architecture of Parkinson's Disease
The Global Parkinson’s Genetics Program (GP2) is an ambitious five-year program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors and the path to further understanding requires working collaboratively and openly sharing data, processes, and results.
Submit a Cohort
Collaborate with us and submit a cohort to GP2. Fill out our form to get started.
Other Ways to Collaborate
Visit the Monogenic Portal to share information about rare cases and families.
Check out the latest news about GP2.
Introduction to GP2
In the first GP2 blog post, Andrew Singleton, NIH Distinguished Investigator and GP2 Lead, introduces the program's aims, values and vision.
Introducing the GP2 Learning Platform
Training is central to the GP2 effort. Visit our learning platform for training on topics related to Parkinson’s disease genetics.
Latest Blog Posts
Read the latest blogs from GP2’s scientists and collaborators.
A letter to the patient community from Randy Schekman, ASAP Scientific Director
ASAP Scientific Director, Randy Schekman, expresses his personal and professional connection with Parkinson's disease in a letter to the patient community, shared by patient advocate Benjamin Stecher.
How to Blog
Simon Stott, founder of the Science of Parkinson's website and GP2 Working Group member, shares his tips for blogging in Parkinson's research.
Find out about GP2’s working groups and their recently accomplished milestones.